Every Lumera product uses technology that has been studied, published, and used in clinical settings for decades. This page shows you exactly what that technology is, where the evidence comes from, and why it matters.
The Science Behind Lumera
We Don't Invent Science.
We Bring It Home.
All studies cited relate to the underlying technologies, not Lumera devices specifically. Individual results vary.
Two Technologies. Decades of Research.
Neuromuscular Electrical Stimulation (NMES)
Sends targeted electrical pulses directly into skeletal muscle, causing it to contract without voluntary effort. Used in clinical rehabilitation for post-surgical recovery, stroke rehabilitation, and spinal muscle reactivation since the 1980s.
See The NMES Research →Photobiomodulation (Red Light Therapy)
Uses specific wavelengths of red and near-infrared light to support the body's natural recovery processes. Published in The Lancet, BMJ Open, and dozens of peer-reviewed rehabilitation journals.
See The Red Light Research →
Technology 1
Neuromuscular Electrical Stimulation
Neuromuscular Electrical Stimulation
What It Is. What It Does. What The Research Says.
NMES sends targeted electrical pulses into skeletal muscle, causing the muscle to contract. Unlike TENS, which stimulates surface nerves to block pain signals, NMES works deeper. It reaches the muscles themselves.
In clinical rehabilitation, NMES has been used for over 40 years to reactivate muscles that patients cannot voluntarily contract. This includes post-surgical quadriceps reactivation, stroke rehabilitation, and the reactivation of the deep lumbar stabilising muscles (the multifidus) in people with chronic lower back pain.
The core clinical insight is simple: when your back is in pain, your body protects itself by switching off the deep muscles around the affected area. These muscles often do not spontaneously recover even when the pain resolves. NMES is designed to bypass that protection response and directly stimulate those muscles back into function.
Published Research on NMES for Lumbar Muscle Reactivation
NATURE (SCIENTIFIC REPORTS)
Combined NMES with Motor Control Exercise Improves Multifidus Activation
A randomised study of 60 participants (25 healthy, 35 with recurrent low back pain) found that NMES combined with motor control exercise produced significantly greater improvement in multifidus activation compared to exercise alone (P < 0.05). The study confirmed that multifidus activation deficits persist even after pain resolves and do not automatically recover.
Songjaroen et al. "Combined NMES with motor control exercise can improve lumbar multifidus activation in individuals with recurrent low back pain." Scientific Reports (Nature), 2021.
HEALTHCARE (MDPI)
Single NMES Session Produces Measurable Multifidus Response at L4 and L5
A randomised study of 30 chronic low back pain patients found significant increases in multifidus muscle stiffness at the L4 vertebral level (p = 0.001) and bilaterally at L5 (p = 0.017 and p = 0.020) after a single NMES treatment session. Both treatment groups also showed statistically significant reductions in pain.
"The Immediate Effect of a Single Treatment of NMES on Multifidus Stiffness in Patients with Chronic Low Back Pain." Healthcare (MDPI), November 2024. PMC11593217.
J. ORTHOPAEDIC & SPORTS PHYSICAL THERAPY
Grade A Evidence Rating for NMES Muscle Reactivation
Clinical Practice Guidelines rated NMES as Grade A evidence — the highest level — and strongly recommended it for improving muscle strength during rehabilitation. This represents the strongest possible recommendation based on the quality and consistency of available evidence.
Logerstedt et al. Clinical Practice Guidelines: Knee Stability and Movement Coordination Impairments. Journal of Orthopaedic & Sports Physical Therapy, 2017.
This Grade A rating was awarded for NMES in knee rehabilitation. The underlying technology and mechanism of action (electrical stimulation causing involuntary muscle contraction) is the same across application sites.
PHYSIOTHERAPY THEORY & PRACTICE
NMES Improved Multifidus Contractility from 68% to 97%
In a published case study, NMES combined with motor control exercise improved lumbar multifidus muscle contractility from 68.1% to 97.7% on the affected side and from 74.2% to 86.7% on the contralateral side. The patient also demonstrated improved movement smoothness.
Songjaroen et al. "Neuromuscular responses to combined NMES and motor control exercises in a patient with recurrent low back pain." Physiotherapy Theory and Practice, Volume 40, Issue 1, 2024. PubMed PMID: 35854425.
This was a single-subject case study, not a large randomised trial. Results from individual case studies may not be representative of typical outcomes.
DISABILITY AND REHABILITATION
Functional NMES During Movement May Outperform Conventional NMES at Rest
A 2026 randomised controlled trial at Hacettepe University investigated NMES techniques applied to the multifidus muscle in people with chronic nonspecific low back pain. The study found that functional NMES applied during movement may produce greater benefits than conventional stimulation at rest.
Disability and Rehabilitation, 2026. Hacettepe University, Turkey.
What This Means For Lumera
The Lumera Deep Muscle Activator uses general NMES technology to deliver targeted electrical stimulation to the deep muscles around the lumbar spine. It is not a medical treatment and does not claim to treat any specific condition.
What the research above demonstrates is that NMES as a technology category has a substantial and growing evidence base for muscle reactivation, particularly in the lumbar multifidus. Lumera brings this clinical technology home in a format that is wireless, simple to use, and backed by a 365-day guarantee.
Technology 2
Photobiomodulation (Red Light Therapy)
Photobiomodulation (Red Light Therapy)
What It Is. What It Does. What The Research Says.
Red light therapy, clinically known as photobiomodulation (PBM), uses specific wavelengths of red and near-infrared light (typically 630–850nm) to stimulate natural biological processes at the cellular level.
The primary mechanism involves the absorption of light by mitochondria, the energy-producing structures inside your cells. When red and near-infrared light reaches the mitochondria, it enhances ATP (adenosine triphosphate) production, modulates inflammatory mediators, increases local blood flow through nitric oxide release, and activates cellular repair pathways.
In plain language: the light gives your cells more energy to do what they already do. Repair tissue. Reduce inflammation. Recover from strain.
PBM has been studied in thousands of published papers and used clinically across physiotherapy, sports medicine, dermatology, and pain management for over three decades.
Published Research on Photobiomodulation
THE LANCET
Meta-Analysis of Low-Level Laser Therapy for Pain Management
A systematic review and meta-analysis of 16 randomised controlled trials published in The Lancet found that low-level laser therapy reduced pain immediately after treatment in acute cases and for up to 22 weeks after completion of treatment in chronic cases. The research was conducted across the University of Sydney, Leeds Metropolitan University, University of São Paulo, and Bergen University College.
Chow RT, Johnson MI, Lopes-Martins RAB, Bjordal JM. "Efficacy of low-level laser therapy in the management of neck pain." The Lancet, 374(9705), 1897–1908, 2009. PMID: 19913903.
BMJ OPEN
22 Randomised Trials: Low-Level Laser Therapy for Knee Osteoarthritis
A systematic review and meta-analysis of 22 randomised placebo-controlled trials (1,063 participants) examined low-level laser therapy for knee osteoarthritis. The review searched PubMed, Embase, CINAHL, PEDro, and Cochrane databases and investigated dose-response relationships using World Association for Laser Therapy treatment recommendations.
Stausholm MB et al. "Efficacy of low-level laser therapy on pain and disability in knee osteoarthritis: systematic review and meta-analysis of randomised placebo-controlled trials." BMJ Open, 9(10), e031142, October 2019. PMID: 31662383.
JOURNAL OF PAIN RESEARCH
Photobiomodulation Ranked #1 for Post-Exercise Recovery
A 2024 Bayesian network meta-analysis compared physical therapy modalities for delayed onset muscle soreness (DOMS). The study searched PubMed, Embase, and Cochrane databases and included multiple randomised controlled trials. Photobiomodulation therapy was ranked as the top intervention at 24 hours post-exercise, outperforming cold water immersion, massage, compression, and active recovery.
"A Bayesian network meta-analysis comparing physical therapy modalities for DOMS." Journal of Pain Research, 2024. doi: 10.2147/JPR.S519242.
PHYSICAL THERAPY (OXFORD)
Systematic Review: Photobiomodulation for Knee Pain and Disability
A 2024 systematic review with meta-analysis searched PubMed, EMBASE, Web of Science, and Cochrane databases through October 2023 to investigate the effects of photobiomodulation in patients with knee osteoarthritis. The review compared PBM with placebo to understand its true clinical effects on pain and functional improvement.
Oliveira S et al. "Effectiveness of Photobiomodulation in Reducing Pain and Disability in Patients With Knee Osteoarthritis." Physical Therapy, Volume 104, Issue 8, August 2024. doi: 10.1093/ptj/pzae073.
IEEE JOURNAL
How Photobiomodulation Works at the Cellular Level
The proposed mechanisms of photobiomodulation include enhanced mitochondrial adenosine triphosphate (ATP) production, modulation of inflammatory mediators (including TNF-α and IL-6), increased microcirculation through nitric oxide release, and activation of cellular repair pathways. Clinical efficacy appears to be dose-dependent, with therapeutic outcomes commonly associated with wavelengths in the 630–1064nm range.
de Freitas LF, Hamblin MR. "Proposed mechanisms of photobiomodulation or low-level light therapy." IEEE Journal of Selected Topics in Quantum Electronics, 22(3), 2016. doi: 10.1109/JSTQE.2016.2561201.
What This Means For Lumera
The Lumera Red Light Panel and Red Light Mat use photobiomodulation technology to deliver specific wavelengths of red and near-infrared light for home use. They are not medical devices and do not claim to treat any specific condition.
What the research above demonstrates is that photobiomodulation as a technology category has been published in The Lancet, BMJ Open, and dozens of peer-reviewed journals spanning pain management, muscle recovery, joint comfort, and tissue repair. Lumera brings this clinically studied technology home in formats that are simple to use and backed by a 365-day guarantee.
Two Technologies. Different Targets. Same Standard of Evidence.
| ⚡ NMES | ☀ Red Light Therapy | |
|---|---|---|
| What it does | Causes involuntary muscle contraction through electrical stimulation | Stimulates cellular energy production through light wavelengths |
| What it targets | Skeletal muscle (specifically deep stabilising muscles) | Cells, tissue, joints, skin |
| Clinical use since | 1980s | 1990s |
| Published in | Nature, PubMed, European Spine Journal | The Lancet, BMJ Open, Journal of Pain Research |
| Evidence level | Grade A for muscle reactivation | Meta-analyses across 1,000+ participants |
| Used clinically | Physiotherapy, post-surgical rehab, stroke recovery | Sports medicine, pain management, dermatology |
| Lumera products | Deep Muscle Activator | Red Light Panel, Red Light Mat |
What We Claim. And What We Don't.
We claim that Lumera products use clinically studied technologies. That is true and the evidence is cited above.
We do not claim that Lumera devices have been individually tested in clinical trials. They have not. The research cited on this page relates to NMES and photobiomodulation as technology categories, not to Lumera products specifically.
We do not claim that our products treat, cure, or prevent any medical condition. They don't. They are wellness devices designed for home use.
We do not claim that every person will experience the same results. They won't. Individual outcomes vary based on condition, consistency of use, and many other factors.
We believe you deserve to know exactly what the evidence says and exactly where it stops. This page is that line.
If you have a medical condition, please consult your doctor before using any Lumera product.